Table 1.
Positive biomarkers and mutated genes analysed by pyrosequencing, in situ hybridisation, IHC and NGS for G52 and G53 tumour samples
Pyrosequencing | G52 Tumour | G53 Tumour |
---|---|---|
Pyro SEQ-MGMT | Unmethylated | Unmethylated |
In situ hybridisation | ||
EGFR | Positive | Positive |
IHC | ||
EGFR | Positive | Positive |
PTEN | Positive | Positive |
TOPIIA | Positive | Positive |
PGP | Positive | Positive |
Next generation sequencing | ||
PTEN | Mutated | Mutated |
EGFR | Mutated | Mutated |
MAP3KI | Mutated | Mutated |
NTRKI | Mutated | Mutated |
TP53 | Wild-type | Mutated |